Author:
Li Guiying,Wang Bin,Li Dongyan,Zhu Rong,Chen Xueyan
Abstract
AbstractMegakaryocytes are common in the bone marrow and appear less often in circulation. Most studies on circulatory megakaryocytes have implicated myelodysplastic syndromes and myeloproliferative disorders because of disruption of the bone marrow barrier and extramedullary hematopoiesis that is commonly seen in the spleen. As myeloproliferative disorders progress, particularly in the absence of the spleen, it is very likely that considerable numbers of megakaryocytes are present in the circulation. Myeloproliferation is associated with essential thrombocytosis or leukocytosis and is the leading cause of pseudo-hyperkalemia followed by reactive thrombocytosis due to splenectomy, rheumatoid arthritis, and renal cancer. The simultaneous measurement of plasma potassium is required when the platelet count exceeds 500 × 109/L and the level of serum potassium is > 5.4 mmol/L.
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Zhu J, Guo W, Wang B. Megakaryocytes in peripheral blood smears of non-hematological diseases. Int J Hematol. 2020;112(1):128–30.
2. Sale S, Rocco V, Pancione Y, Carri DD, Fumi M, Bain BJ. A confusing “white cell count”: circulating micromegakaryocytes in post-thrombocythemia myelofibrosis. Am J Hematol. 2019;94(5):617–8.
3. Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010;102(3):83–7.
4. Erber WN, Jacobs A, Oscier DG, O’Hea AM, Mason DY. Circulating micromegakaryocytes in myelodysplasia. J Clin Pathol. 1987;40(11):1349–52.
5. Ong YL, Deore R, El-Agnaf M. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients. Int J Lab Hematol. 2010;32(1 Pt 1):e151–7.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献